Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease

Mohammed Alqabasani; Nawaf Alkherayf; Andrea Lasso; Shaun Kilty

doi:10.5152/ejra.2022.22010

Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease

Abstract

Background: Aspirin-exacerbated respiratory disease is characterized by asthma, chronic rhinosinusitis with nasalpolyps, and sensitivity to aspirin and other cyclooxygenase-1 inhibitors. The use of medical identification by patients with aspirin-exacerbated respiratory disease can provide essential information to prevent accidental exposure to cyclooxygenase-1 inhibitor medications. There is no available literature on medical identification use in the aspirin-exacerbated respiratory disease patient population. Methods: A cross-sectional survey study was designed to measure the perception of the need for a medical identification and its use by the patients diagnosed with aspirin-exacerbated respiratory disease at The Ottawa Hospital. Results: Six hundred eighty patients were identified in our registry with a documented sensitivity to nonsteroidal anti-inflammatory drugs or aspirin; 12 additional patients were identified during a clinical visit. A total of 68 patients withaspirin-exacerbated respiratory disease met the inclusion criteria. Twenty-one patients were successfully enrolled. The majority (81%, n = 17) of the patients were not using any medical identification. The most common reason reported by patients for not using the medical identification was a lack of knowledge and awareness regarding its significance. Conclusion: In this survey of patients with aspirin-exacerbated respiratory disease, patients were found to have little knowledge regarding the benefits of medical identification use. Subsequently, medical identification use was very limited, supporting a clear need for further patient education and awareness.

Keywords

References

Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89(5):474-478.
Szczeklik A, Nizankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol. 2001;1(1):27-33.
Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28-39.
Savino PB, Sporer KA, Barger JA, et al. Chest pain of suspected cardiac origin: current evidence-based recommendations for prehospital care. West J Emerg Med. 2015;16(7):983-995.
Zideman DA, Singletary EM, De Buck EDJ, et al. Resuscitation-Part 9: First aid: 2015 International Consensus on First Aid Science with treatment recommendations. Resuscitation. 2015;95:e225-e261.
Quan D, LoVecchio F, Clark B, Gallagher JV, 3rd. Prehospital use of aspirin rarely is associated with adverse events. Prehosp Disaster Med. 2004;19(4):362-365.
Morton L, Murad S, Omar RZ, Taylor K. Importance of emergency identification schemes. Emerg Med J. 2002;19(6):584-586. [CrossRef]
Kiladejo A, Palumbo M, Laidlaw TM. Accidental ingestion of aspirin and nonsteroidal anti-inflammatory drugs is common in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019;7(5): 1656-1658.e2.

Buhl T, Meynberg HC, Kaune KM, Hünecke P, Schön MP, Fuchs T. Long-term follow-up of patients with hypersensitivity to nonsteroidal anti-inflammatory drugs reveals shortcomings in compliance and care. J Allergy Clin Immunol. 2011;127(1):284-285.
Aun MV, Blanca M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-420.
Chadwick S, Shah M. Tattoos: ancient body art may assist in medical emergencies. Eur J Pediatr. 2013;172(7):995.
Rahman S, Walker D, Sultan P. Medical identification or alert jewellery: an opportunity to save lives or an unreliable hindrance? Anaesthesia. 2017;72(9): 1139-1145.
Barot PA, Malhotra SD, Rana DA, Patel VJ, Patel KP. Drug utilization in emergency medicine department at a tertiary care teaching hospital: a prospective study. J Basic Clin Pharm. 2013;4(4):78-81.
MedicAlert Foundation; 2022. Available at: https://www.medicalert.org/. Accessed February 10, 2022.
Stallwood L. Medical alert identification: a “scarlet letter” or tool for diabetes management. J Pediatr Health Care. 2005;19(6):400-404.
Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7(12):657-660.
Gorlin JB, Hooke MC, Leonard N. Use of emergency medical identification in the paediatric haemophilia population: a national study. Haemophilia. 2011;17(2):215-222.
Vachharajani T. Medical alert bracelet: an effective way to preserve veins for future dialysis vascular access in patients with chronic kidney disease. Medscape J Med. 2009;11(1):1.
Alzheimer’s Society of Canada. Medicalert, safely home. Alzheimer's Society of Canada; 2022. Available at: https://alzheimer.ca/en/help-support/programs-services/medicalert-safely-home. Accessed Feb 14, 2022.
Le T-TA, Foreman C, Smith WB. The use of medical alert jewelry to communicate allergy information. J Allergy Clin Immunol Pract. 2019;7(3):1083-1085.
Farhy E, Diamantidis CJ, Doerfler RM, Fink WJ, Zhan M, Fink JC. Use of a medical-alert accessory in CKD: a pilot study. Clin J Am Soc Nephrol. 2019;14(7):994-1001.
Grüninger UJ. Patient education: an example of one-to-one communication. J Hum Hypertens. 1995;9(1):15-25.
Kennedy JM, Vargus B. Challenges in survey research and their implications for philanthropic studies research. Nonprofit Volunt Sect Q. 2001;30(3):483-494.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Authors

Mohammed Alqabasani This is me
Canada

Nawaf Alkherayf This is me
Canada

Andrea Lasso This is me
0000-0002-9552-264X
Canada

Shaun Kilty This is me
0000-0003-1857-7628
Canada

Publication Date

August 1, 2022

Submission Date

May 30, 2022

Acceptance Date

June 30, 2022

Published in Issue

Year 2022 Volume: 5 Number: 2

DOI

https://doi.org/10.5152/ejra.2022.22010

IZ

https://izlik.org/JA68XP36NJ

Cite

RIS / Bibtex

APA

Alqabasani, M., Alkherayf, N., Lasso, A., & Kilty, S. (2022). Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease. European Journal of Rhinology and Allergy, 5(2), 31-34. https://doi.org/10.5152/ejra.2022.22010

AMA

1.Alqabasani M, Alkherayf N, Lasso A, Kilty S. Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease. Eur J Rhinol Allergy. 2022;5(2):31-34. doi:10.5152/ejra.2022.22010

Chicago

Alqabasani, Mohammed, Nawaf Alkherayf, Andrea Lasso, and Shaun Kilty. 2022. “Medical Identification Use in Patients With Aspirin-Exacerbated Respiratory Disease”. European Journal of Rhinology and Allergy 5 (2): 31-34. https://doi.org/10.5152/ejra.2022.22010.

EndNote

Alqabasani M, Alkherayf N, Lasso A, Kilty S (August 1, 2022) Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease. European Journal of Rhinology and Allergy 5 2 31–34.

IEEE

[1]M. Alqabasani, N. Alkherayf, A. Lasso, and S. Kilty, “Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease”, Eur J Rhinol Allergy, vol. 5, no. 2, pp. 31–34, Aug. 2022, doi: 10.5152/ejra.2022.22010.

ISNAD

Alqabasani, Mohammed - Alkherayf, Nawaf - Lasso, Andrea - Kilty, Shaun. “Medical Identification Use in Patients With Aspirin-Exacerbated Respiratory Disease”. European Journal of Rhinology and Allergy 5/2 (August 1, 2022): 31-34. https://doi.org/10.5152/ejra.2022.22010.

JAMA

1.Alqabasani M, Alkherayf N, Lasso A, Kilty S. Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease. Eur J Rhinol Allergy. 2022;5:31–34.

MLA

Alqabasani, Mohammed, et al. “Medical Identification Use in Patients With Aspirin-Exacerbated Respiratory Disease”. European Journal of Rhinology and Allergy, vol. 5, no. 2, Aug. 2022, pp. 31-34, doi:10.5152/ejra.2022.22010.

Vancouver

1.Mohammed Alqabasani, Nawaf Alkherayf, Andrea Lasso, Shaun Kilty. Medical Identification Use in Patients with Aspirin-Exacerbated Respiratory Disease. Eur J Rhinol Allergy. 2022 Aug. 1;5(2):31-4. doi:10.5152/ejra.2022.22010